Literature DB >> 23993201

A 2-wk conservative treatment regimen preceding thoracic duct ligation is effective and safe for treating post-esophagectomy chylothorax.

Wei Li1, Gang Dan, Jianqing Jiang, Yongfan Zhao, Dan Deng.   

Abstract

BACKGROUND: Chylothorax is a pathologic condition defined by an accumulation of lymphatic fluid, the chyle, in the thorax. Postoperative chylothorax is a potentially lethal complication, with a reported mortality rate of 15.4%-25%. PATIENTS AND METHODS: Esophageal cancer patients hospitalized for elective radical esophagectomy by thoracotomy (n = 10,574) were consecutively enrolled between January 1996 and December 2011. Patients (n = 306) who experienced post-esophagectomy chylothorax were assigned to a 48-h (group A, n = 186) or to a 2-wk (group B, n = 120) conservative treatment regimen. For patients with a daily chylothorax output >1000 mL, thoracic duct ligation (TDL) was performed by thoracotomy. Measured outcomes included frequency of TDL, overall and treatment-specific morbidity and mortality rates, and the rate of chylothorax recurrence.
RESULTS: A total of 171 patients (171 of 306 [55.9%]) underwent TDL. A larger proportion of patients in group A required TDL compared with group B (72.6% versus 30.0%, P < 0.001). Group A had a significantly higher rate of overall morbidity compared with group B (31.7% versus 19.2%, P = 0.02). Moreover, the overall mortality rate was significantly higher in group A (14.0% versus 4.2%, P = 0.006). Chylothorax recurred in nine patients (9 of 306 [2.9%]), and there was no difference between the two groups (3.2% versus 2.5%, P = 1.000).
CONCLUSIONS: The 2-wk regimen reduced the requirement for TDL and the overall morbidity and mortality rates compared with the 48-h regimen. Importantly, this regimen does not increase the risk of chylothorax recurrence. Crown
Copyright © 2013. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chylothorax; Conservative treatment; Ligation; Morbidity; Mortality; Pleural cavity; Postoperative; Thoracic duct; Thrombosis

Mesh:

Year:  2013        PMID: 23993201     DOI: 10.1016/j.jss.2013.07.012

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  3 in total

1.  Incidence and management of chylothorax after esophagectomy.

Authors:  Longsheng Miao; Yawei Zhang; Hong Hu; Longfei Ma; Yihua Shun; Jiaqing Xiang; Haiquan Chen
Journal:  Thorac Cancer       Date:  2015-02-26       Impact factor: 3.500

2.  Risk Factors, Diagnosis and Management of Chyle Leak Following Esophagectomy for Cancers: An International Consensus Statement.

Authors:  Sivesh K Kamarajah; Manjunath Siddaiah-Subramanya; Alessandro Parente; Richard P T Evans; Ademola Adeyeye; Alan Ainsworth; Alberto M L Takahashi; Alex Charalabopoulos; Andrew Chang; Atila Eroglue; Bas Wijnhoven; Claire Donohoe; Daniela Molena; Eider Talavera-Urquijo; Flavio Roberto Takeda; Gail Darling; German Rosero; Guillaume Piessen; Hans Mahendran; Hsu Po Kuei; Ines Gockel; Ionut Negoi; Jacopo Weindelmayer; Jari Rasanen; Kebebe Bekele; Guowei Kim; Lieven Depypere; Lorenzo Ferri; Magnus Nilsson; Frederik Klevebro; B Mark Smithers; Mark I van Berge Henegouwen; Peter Grimminger; Paul M Schneider; C S Pramesh; Raza Sayyed; Richard Babor; Shinji Mine; Simon Law; Suzanne Gisbertz; Tim Bright; Xavier Benoit D'Journo; Donald Low; Pritam Singh; Ewen A Griffiths
Journal:  Ann Surg Open       Date:  2022-08-29

3.  Management of chyle leaks following esophageal resection: a systematic review.

Authors:  Robert Power; Philip Smyth; Noel E Donlon; Timothy Nugent; Claire L Donohoe; John V Reynolds
Journal:  Dis Esophagus       Date:  2021-11-11       Impact factor: 3.429

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.